How Did a Stanford Surgeon and a Jiu-Jitsu Black Belt End Up Rewriting the Rules of Joint Health?
It's Sunday, June 15th. Maybe you're sipping coffee, catching your breath from the week, or trying to figure out why your back randomly hurts now even though you did literally nothing yesterday.
Been there.
But while you’re here, let me tell you a story that might just change how you think about joint pain and maybe even where you put your money.
Let’s talk about a guy named Dr. Gaetano Scuderi.
Not Your Average Surgeon
Dr. Scuderi is the kind of person you'd want in your corner, literally. He’s a world-class spine surgeon trained at Stanford... and a black belt in Brazilian Jiu-Jitsu. So yeah, he knows a thing or two about pain both as a doctor and as someone who’s likely taken a few knees to the ribs.
He’s been teaching and training since the '90s. He’s helped thousands of people walk again. But something kept bugging him: Why are we just managing joint pain when we could be solving it?
That simple question took him on a path that changed everything.
From the Operating Room to the Lab
You know how your body has all these built-in defense systems? Turns out one of those systems includes a little protein called alpha-2-macroglobulin or A2M, if you’re not in the mood for a tongue-twister.
A2M is like your cartilage’s personal bouncer. Its job? Block the enzymes (called proteases) that break down your joints over time.
The catch? Your body doesn’t send enough of it to the right place. So your joints get chewed up like they owe someone money.
Dr. Scuderi figured out how to pull that protein from your blood, super-concentrate it, and inject it right into the problem area. That therapy, called APIC worked so well, the FDA cleared it, and over 10,000 patients across the U.S. have been treated with it.
But that was just step one.
Making a Good Thing Even Better
Scuderi being Scuderi, he didn’t stop there.
He thought: “Why are we relying on the body's limited supply of A2M when we can build a better version ourselves?”
So that’s what he did.
He and his team created CYT-108, a genetically engineered version of A2M that’s:
- Over 200% more effective at blocking those nasty cartilage-chewing enzymes
- Injected right into joints for max impact
- Designed to slow down or even stop joint breakdown before it leads to surgery
This isn’t just another "joint support supplement" from the vitamin aisle. This is next-level, science-backed therapy built to change the rules of how we treat joint pain.
Why Are We Talking About This Today?
Because on this Sunday in mid-June, you might be wondering:
- Why are so many of us limping into our 50s?
- Why are joint replacements considered a normal part of aging?
- And why hasn’t anyone really fixed this yet?
That’s the same frustration Dr. Scuderi felt. So he did something about it. And now, you can be part of the solution too.
Wait, I Can Invest in This?
Yup.
Cytonics, the biotech company Dr. Scuderi founded; isn’t just looking for science journals and FDA approvals. They’re opening the door to everyday people, not just Wall Street.
- The company’s already raised $25M+ from regular folks
- Over 6,000 investors have come onboard
- They’ve got 24+ patents protecting the science
- And they’re now entering Phase 2 trials for CYT-108
That means the science is moving and the opportunity is still open.
Final Thought
If you’re tired of quick fixes, recurring prescriptions, and being told that "joint pain is just part of getting older." Then maybe it’s time to bet on something better.
Because if a Stanford-trained surgeon and a jiu-jitsu black belt can shake up the system…
Maybe it’s time your investments did too.
Let’s make smarter medicine and smarter moves, together.
Your knees might thank you.
So might your portfolio.
Your move.
*Reg A Disclaimer:
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You may obtain a copy of the offering circular here.